Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13880
Country/Region: Uganda
Year: 2014
Main Partner: Makerere University
Main Partner Program: School of Public Health
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $4,384,152 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

Makerere University School of Public health-Rakai Health Sciences Program (MUSPH-RHSP) will continue to develop and strengthen the national of public health workforce in Uganda and also continue delivery of comprehensive HIV/AIDS prevention, care and treatment services in the Rakai District. The workforce development program will support and strengthen the existing HIV fellowship program that provides leadership and management capacity building programs with a national coverage, targeting health service providers and managers across all the 112 districts. Additionally, the program will support monitoring and evaluation of district health programs, enhance country ownership and sustainability. MUSPH-RHSP will also implement the comprehensive HIV care and treatment component in Rakai district. RHSP will support Rakai district to offer comprehensive HIV/AIDS services to children, adolescents and adults in line with the national guidelines and will provide technical assistance to the district to plan and integrate Global Health Initiative principles into HIV/AIDS and other health services. The HIV/AIDS services will include PMTCT, HIV counseling and testing, Male circumcision, TB/HIV, ART, health system strengthening and laboratory support. These services will be implemented in collaboration with the other implementing partners to harness synergy, ensure sustainability and ownership. The major goals of this program will be to support scale-up of HIV prevention services under district-led programming, scale up of voluntary medical male circumcision, scale up of comprehensive HIV and TB care and treatment services under the leadership of Rakai district health office; and to conduct combination prevention impact evaluation in Rakai district.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $80,105
Care: TB/HIV (HVTB) $80,553
Care: Pediatric Care and Support (PDCS) $11,327
Laboratory Infrastructure (HLAB) $60,000
Strategic Information (HVSI) $750,000
Health Systems Strengthening (OHSS) $1,200,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $535,850
Testing: HIV Testing and Counseling (HVCT) $52,716
Sexual Prevention: Other Sexual Prevention (HVOP) $77,632
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $153,909
Treatment: Adult Treatment (HTXS) $1,288,341
Treatment: Pediatric Treatment (PDTX) $93,719
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D By Age: <15 2015 870
C2.1.D By Age: <15 2015 648
C2.1.D By Age: 15+ 2015 10,286
C2.1.D By Age: 15+ 2015 7,768
C2.1.D By Age/Sex: <15 Female 2015 502
C2.1.D By Age/Sex: <15 Female 2015 345
C2.1.D By Age/Sex: <15 Male 2015 368
C2.1.D By Age/Sex: <15 Male 2015 303
C2.1.D By Age/Sex: 15+ Female 2015 6,727
C2.1.D By Age/Sex: 15+ Female 2015 5,117
C2.1.D By Age/Sex: 15+ Male 2015 3,559
C2.1.D By Age/Sex: 15+ Male 2015 2,651
C2.1.D By Sex: Female 2015 7,229
C2.1.D By Sex: Female 2015 5,470
C2.1.D By Sex: Male 2015 3,927
C2.1.D By Sex: Male 2015 2,946
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 11,156
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 8,416
C2.1.D Sum of Age disaggregates 2015 11,156
C2.1.D Sum of Age disaggregates 2015 8,416
C2.1.D Sum of Age/Sex disaggregates 2015 11,156
C2.1.D Sum of Age/Sex disaggregates 2015 8,416
C2.1.D Sum of Sex disaggregates 2015 11,156
C2.1.D Sum of Sex disaggregates 2015 8,416
C2.1.D_NGI By Age: <15 2015 1,507
C2.1.D_NGI By Age: 15+ 2015 18,065
C2.1.D_NGI By Age/Sex: <15 Female 2015 802
C2.1.D_NGI By Age/Sex: <15 Male 2015 705
C2.1.D_NGI By Age/Sex: 15+ Female 2015 11,900
C2.1.D_NGI By Age/Sex: 15+ Male 2015 6,165
C2.1.D_NGI By Sex: Female 2015 12,722
C2.1.D_NGI By Sex: Male 2015 6,850
C2.1.D_NGI Number of HIV-positive individuals receiving a minimum of one clinical service 2015 19,572
C2.1.D_NGI Sum of Age disaggregates 2015 19,572
C2.1.D_NGI Sum of Age/Sex disaggregates 2015 19,572
C2.1.D_NGI Sum of Sex disaggregates 2015 19,572
C2.4.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 8,416
C2.4.D Number of HIV-positive patients who were screened for TB in HIV care or treatment setting 2015 18,924
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 502
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 379
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 368
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 278
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 6,727
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 5,075
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 3,559
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 2,685
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 11,156
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 8,417
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 11,156
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 8,417
CARE_NEW Aggregated Age/sex: <15 Female 2015 101
CARE_NEW Aggregated Age/sex: <15 Male 2015 109
CARE_NEW Aggregated Age/sex: 15+ Female 2015 1,502
CARE_NEW Aggregated Age/sex: 15+ Male 2015 758
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 2,470
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 2,470
FN_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 2
FN_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 2
FN_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 18
FN_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 18
FN_SITE Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 20
FN_SITE Sum of Numerator Support Type disaggregates 2015 20
FN_SITE Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 26
FN_SITE_den Sum of Denominator Support Type disaggregates 2015 20
FN_THER Aggregated Age: <18 2015 289
FN_THER Aggregated Age: 18+ 2015 181
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2015 505
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2015 6,308
FN_THER Sum of Aggregated Age disaggregates 2015 470
HRH_PRE By Graduates: Other 2015 43
HRH_PRE By new graduates who are licensed and registered: Other (where applicable) 2015 43
HRH_PRE Sum of Graduates disaggregates 2015 43
HTS_TST Age/sex: 10-14 Female 2015 999
HTS_TST Age/sex: 10-14 Female 2015 999
HTS_TST Age/sex: 10-14 Male 2015 858
HTS_TST Age/sex: 10-14 Male 2015 858
HTS_TST Age/sex: 15-19 Female 2015 5,390
HTS_TST Age/sex: 15-19 Female 2015 5,390
HTS_TST Age/sex: 15-19 Male 2015 942
HTS_TST Age/sex: 15-19 Male 2015 942
HTS_TST Age/sex: 20-24 Female 2015 4,716
HTS_TST Age/sex: 20-24 Female 2015 4,716
HTS_TST Age/sex: 20-24 Male 2015 790
HTS_TST Age/sex: 20-24 Male 2015 790
HTS_TST Age/sex: 25-49 Female 2015 12,352
HTS_TST Age/sex: 25-49 Female 2015 12,352
HTS_TST Age/sex: 25-49 Male 2015 2,083
HTS_TST Age/sex: 25-49 Male 2015 2,083
HTS_TST Age/sex: 5-9 Female 2015 1,324
HTS_TST Age/sex: 5-9 Female 2015 1,324
HTS_TST Age/sex: 50+ Male 2015 95
HTS_TST Age/sex: 50+ Male 2015 95
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 2,323
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 858
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 22,458
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 3,911
HTS_TST Aggregated Age/sex: <15 Female 2015 2,323
HTS_TST Aggregated Age/sex: <15 Male 2015 858
HTS_TST Aggregated Age/sex: 15+ Female 2015 22,458
HTS_TST Aggregated Age/sex: 15+ Male 2015 3,911
HTS_TST By Test Result: Negative 2015 26,410
HTS_TST By Test Result: Negative 2015 10,927
HTS_TST By Test Result: Negative 2015 37,337
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 27,227
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 7,169
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 39,377
HTS_TST Sum of Age/Sex disaggregates 2015 27,226
HTS_TST Sum of Age/Sex disaggregates 2015 2,323
HTS_TST Sum of Age/Sex disaggregates 2015 29,549
HTS_TST Sum of Aggregated Age/Sex <15 2015 858
HTS_TST Sum of Aggregated Age/Sex <15 2015 2,323
HTS_TST Sum of Aggregated Age/Sex <15 2015 3,181
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 26,369
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 26,369
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 2,323
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 29,550
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 27,227
HTS_TST Sum of Test Result disaggregates 2015 27,227
HTS_TST Sum of Test Result disaggregates 2015 12,151
HTS_TST Sum of Test Result disaggregates 2015 39,377
HTS_TST_POS By Test Result: Positive 2015 817
HTS_TST_POS By Test Result: Positive 2015 1,224
HTS_TST_POS By Test Result: Positive 2015 2,040
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2015 1
LAB_ACC Sum of Support Type disaggregates 2015 1
LAB_CAP By clinical laboratories 2015 20
LAB_CAP By site support type: Direct Service Delivery (DSD) 2015 20
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 20
LAB_CAP Sum of Site Support Type disaggregates 2015 20
PMTCT_ARV Life-long ART (including Option B+) 2015 1,096
PMTCT_ARV Life-long ART (including Option B+) 2015 1,454
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 1,218
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 1,615
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 1,096
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 1,454
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 362
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 480
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 735
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 974
PMTCT_ARV Sum of New and Current disaggregates 2015 1,097
PMTCT_ARV Sum of New and Current disaggregates 2015 1,454
PMTCT_ARV Sum of Regimen Type disaggregates 2015 1,096
PMTCT_ARV Sum of Regimen Type disaggregates 2015 1,454
PMTCT_ARV_NGI Life-long ART (including Option B+) 2015 1,454
PMTCT_ARV_NGI Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 1,615
PMTCT_ARV_NGI Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 1,454
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 480
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 974
PMTCT_ARV_NGI Sum of New and Current disaggregates 2015 1,454
PMTCT_ARV_NGI Sum of Regimen disaggregates 2015 1,454
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2015 1,292
PMTCT_EID By infants with a positive virologic test result within 12 months of birth 2015 81
PMTCT_EID Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) 2015 1,615
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2015 1,292
PMTCT_EID Sum of Infant Age disaggregates 2015 1,292
PMTCT_STAT By: Known positives at entry 2015 614
PMTCT_STAT By: Number of new positives identified 2015 1,001
PMTCT_STAT Number of new ANC and L&D clients 2015 24,286
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 23,071
PMTCT_STAT Sum of Positives Status disaggregates 2015 1,615
PMTCT_STAT_NGI By: Known positives at entry 2015 614
PMTCT_STAT_NGI By: Number of new positives identified 2015 1,001
PMTCT_STAT_NGI Number of new ANC and L&D clients 2015 24,286
PMTCT_STAT_NGI Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 23,071
PMTCT_STAT_NGI Sum of Positives Status disaggregates 2015 1,615
PP_PREV Age/sex: 10-14 Female 2015 845
PP_PREV Age/sex: 10-14 Female 2015 378
PP_PREV Age/sex: 10-14 Male 2015 845
PP_PREV Age/sex: 10-14 Male 2015 629
PP_PREV Age/sex: 15-19 Female 2015 2,548
PP_PREV Age/sex: 15-19 Female 2015 1,346
PP_PREV Age/sex: 15-19 Male 2015 392
PP_PREV Age/sex: 15-19 Male 2015 1,204
PP_PREV Age/sex: 20-24 Female 2015 2,219
PP_PREV Age/sex: 20-24 Female 2015 1,128
PP_PREV Age/sex: 20-24 Male 2015 324
PP_PREV Age/sex: 20-24 Male 2015 1,010
PP_PREV Age/sex: 25-49 Female 2015 5,830
PP_PREV Age/sex: 25-49 Female 2015 2,976
PP_PREV Age/sex: 25-49 Male 2015 843
PP_PREV Age/sex: 25-49 Male 2015 2,666
PP_PREV Age/sex: 50+ Female 2015 273
PP_PREV Age/sex: 50+ Male 2015 148
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2015 13,846
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2015 11,759
PP_PREV Sum of Age/Sex disaggregates 2015 13,846
PP_PREV Sum of Age/Sex disaggregates 2015 11,758
PP_PREV Total number of people in the target population 2015 23,517
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 25
SITE_SUPP By program area/support type: HTC Direct Service Delivery (DSD) 2015 27
SITE_SUPP By program area/support type: Lab Direct Service Delivery (DSD) 2015 26
SITE_SUPP By program area/support type: PMTCT Direct Service Delivery (DSD) 2015 26
SITE_SUPP By program area/support type: PMTCT Technical Assistance-only (TA) 2015 1
SITE_SUPP By program area/support type: TB/HIV Direct Service Delivery (DSD) 2015 3
SITE_SUPP By program area/support type: TB/HIV Technical Assistance-only (TA) 2015 13
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 26
SITE_SUPP By program area/support type: VMMC Direct Service Delivery (DSD) 2015 15
SITE_SUPP Number of unique sites supported by PEPFAR 2015 27
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2015 2,360
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2015 15,254
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 8,417
TB_SCREEN Sex: Female 2015 11,485
TB_SCREEN Sex: Male 2015 6,130
TB_SCREEN Sum of Aggregated Age disaggregates 2015 17,614
TB_SCREEN Sum of Sex disaggregates 2015 17,615
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 17,615
TX_CURR Aggregated Age/Sex: <15 Female 2015 405
TX_CURR Aggregated Age/Sex: <15 Female 2015 319
TX_CURR Aggregated Age/Sex: <15 Male 2015 375
TX_CURR Aggregated Age/Sex: <15 Male 2015 295
TX_CURR Aggregated Age/Sex: 15+ Female 2015 6,214
TX_CURR Aggregated Age/Sex: 15+ Female 2015 4,883
TX_CURR Aggregated Age/Sex: 15+ Male 2015 3,143
TX_CURR Aggregated Age/Sex: 15+ Male 2015 2,469
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 10,633
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 7,966
TX_CURR Sum of Aggregated Age/Sex <15 2015 780
TX_CURR Sum of Aggregated Age/Sex <15 2015 614
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 9,357
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 7,352
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 10,137
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 7,966
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 724
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 670
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 11,097
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 5,612
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 18,103
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 1,394
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 16,709
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 18,103
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 126
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 110
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 2,148
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 837
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 3,221
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 3,221
TX_RET Aggregated Age: <15 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 292
TX_RET Aggregated Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 3,702
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2015 3,994
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2015 4,389
TX_RET_den Aggregated Age: <15 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 320
TX_RET_den Aggregated Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 4,069
VMMC_AE By AE Type: Number of VMMC clients with one or more moderate or severe medical device-related AE(s) 2015 16
VMMC_AE By AE type: Number of VMMC clients with one or more moderate or severe surgical intra-operative AE(s) 2015 27
VMMC_AE By AE Type: Number of VMMC clients with one or more moderate or severe surgical post-operative AE(s) 2015 9
VMMC_AE Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) 2015 16
VMMC_AE Sub-Disag: By Medical device-based AE(s) by maximum severity category: Number of clients with one or more moderate medical device-related AE(s), but no severe medical device-related AE(s) 2015 16
VMMC_AE Sub-Disag: By Medical device-based AE(s) by maximum severity category: Number of clients with one or more severe medical device-related AE(s) 2015 11
VMMC_AE Sub-Disag: By Surgical post-operative AE(s) by maximum severity category: Number of clients with one or more moderate surgical post-operative AE(s), but no severe surgical post-operative AE(s) 2015 8
VMMC_AE Sub-Disag: By Surgical post-operative AE(s) by maximum severity category: Number of clients with one or more severe surgical intra-operative AE(s) 2015 81
VMMC_AE Sub-Disag: Surgical intra-operative AE(s) by maximum severity category: Number of clients with one or more moderate surgical intra-operative AE(s), but no severe surgical intra-operative AE(s) 2015 27
VMMC_AE Sub-Disag: Surgical intra-operative AE(s) by maximum severity category: Number of clients with one or more severe surgical intra-operative AE(s) 2015 11
VMMC_CIRC By Age: 10-14 2015 890
VMMC_CIRC By Age: 15-19 2015 978
VMMC_CIRC By Age: 20-24 2015 819
VMMC_CIRC By Age: 25-49 2015 2,161
VMMC_CIRC By Age: 50+ 2015 99
VMMC_CIRC By circumcision technique: Device-based VMMC 2015 2,234
VMMC_CIRC By circumcision technique: Surgical VMMC 2015 2,713
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2015 2,713
VMMC_CIRC By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2015 1,088
VMMC_CIRC By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2015 3,743
VMMC_CIRC By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2015 116
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2015 4,947
VMMC_CIRC Sum of age disaggregates 2015 4,947
VMMC_CIRC_NGI By Age: 10-14 2015 890
VMMC_CIRC_NGI By Age: 15-19 2015 978
VMMC_CIRC_NGI By Age: 20-24 2015 819
VMMC_CIRC_NGI By Age: 25-49 2015 2,161
VMMC_CIRC_NGI By Age: 50+ 2015 99
VMMC_CIRC_NGI By circumcision technique: Device-based VMMC 2015 2,234
VMMC_CIRC_NGI By circumcision technique: Surgical VMMC 2015 2,713
VMMC_CIRC_NGI By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2015 2,713
VMMC_CIRC_NGI By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2015 1,088
VMMC_CIRC_NGI By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2015 3,743
VMMC_CIRC_NGI By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2015 116
VMMC_CIRC_NGI Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2015 6,114
VMMC_CIRC_NGI Sum of Age disaggregates 2015 4,947
Cross Cutting Budget Categories and Known Amounts Total: $320,000
Motor Vehicles: Purchased $320,000
Key Issues Identified in Mechanism
enumerations.Malaria (PMI)
Child Survival Activities
Safe Motherhood
Tuberculosis
Family Planning